HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Prestige Fragrance Category Gets Intense With Spin-Off Scents

This article was originally published in The Rose Sheet

Executive Summary

A slew of new fragrance entries - including launches by Lancôme, Origins and Clinique - are being positioned as spin-off scents designed to capitalize on the success of existing well-established brands

You may also be interested in...



Clinique Simply Aims To Broadens Appeal Of Oriental Fragrance Family

Clinique will introduce a women's fragrance calledSimply in September, marking the group's first fragrance brand launch since 1997, as well as its first Oriental scent, the Estee Lauder division said

Clinique Simply Aims To Broadens Appeal Of Oriental Fragrance Family

Clinique will introduce a women's fragrance calledSimply in September, marking the group's first fragrance brand launch since 1997, as well as its first Oriental scent, the Estee Lauder division said

Calvin Klein Eternity, Obsession, CK One Extensions Aim To Drive Sales

Unilever Cosmetics International is relying on extensions to its core Calvin Klein fragrance brands - Eternity, cK one and Obsession - to fuel sales. Launches are planned under all three fragrance families in the first half of 2003, Calvin Klein Cosmetics President Hillary Dart said

Latest Headlines
See All
UsernamePublicRestriction

Register

RS010765

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel